The trinity of COVID-19: immunity, inflammation and intervention

Tay, Matthew Zirui, Poh, Chek Meng, Rénia, Laurent, MacAry, Paul A., Ng, Lisa F. P.·2020·Nature Reviews Immunology
DOI 10.1038/s41577-020-0311-8

Cited by (1,002)

Items 901–1,000 of 1,002

  1. Pathophysiology of the Acute Respiratory Distress Syndrome
    Pratik Sinha, Lieuwe D. J. Bos · 2021 · Critical Care Clinics
  2. Pannexin-1 channel opening is critical for COVID-19 pathogenesis
    Ross H. Luu, Silvana Valdebenito, Eliana Scemes, Antonio Cibelli, David Conover Spray, Maximiliano Rovegno, Juan Enrique Tichauer, Andréa Cottignies-Calamarte, Arielle R. Rosenberg, Calude Capron et al. · 2021 · iScience
  3. Hyperglycemia and blood glucose deterioration are risk factors for severe COVID‐19 with diabetes: A two‐center cohort study
    Fen Xiao, Ying‐Chu Zhou, Mei‐Biao Zhang, Chen Dong, Shao‐Lin Peng, Haoneng Tang, Long Li, Chen‐Yi Tang, Jiyang Liu, Bo Li et al. · 2021 · Journal of Medical Virology
  4. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study
    Natalie J. Atallah, Hailey M. Warren, Matthew Blake Roberts, Ramy H. Elshaboury, Monique R. Bidell, Ronak G. Gandhi, Meagan L. Adamsick, Maryam K. Ibrahim, Rupali Sood, Savo Bou Zein Eddine et al. · 2022 · PLoS ONE
  5. Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review
    Nanda Nursyifa Fadiyah, Ginna Megawati, Dimas Erlangga Luftimas · 2022 · International Journal of General Medicine
  6. Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
    Dominik A. Rothen, Pascal S. Krenger, Aleksandra Nonic, Ina Baļķe, Anne‐Cathrine S. Vogt, Xinyue Chang, Alessandro Manenti, Fabio Vedovi, Gunta Resēviča, Senta M. Walton et al. · 2022 · Allergy
  7. Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity
    Simon Haunhorst, Wilhelm Bloch, Heiko Wagner, Claudia Ellert, Karsten Krüger, Daniel Vilser, Kathrin Finke, Philipp Alexander Reuken, Mathias Wilhelm Pletz, Andreas Stallmach et al. · 2022 · Oxford Open Immunology
  8. COVID-19 and Diabetes: The Importance of Controlling RAGE
    Ernestina Marianna De Francesco, Veronica Vella, Antonino Belfiore · 2020 · Frontiers in Endocrinology
  9. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
    Omalla Allan Olwenyi, Shetty Ravi Dyavar, Arpan Acharya, Anthony T. Podany, Courtney Vail Fletcher, Caroline L. Ng, St Patrick Reid, Siddappa N. Byrareddy · 2020 · Journal of Molecular Medicine
  10. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
    Ludger Klimek, Oliver Pfaar, Margitta Worm, Thomas Eiwegger, Jan Hagemann, Markus W. Ollert, Eva Untersmayr, Karin Hoffmann‐Sommergruber, Alessandra Vultaggio, Ioana Octavia Agache et al. · 2020 · Allergologie select
  11. Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
    Nicola Giesen, Rosanne Sprute, Maria Madeleine Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr et al. · 2020 · European Journal of Cancer
  12. COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments
    Alice Laroni, Irene Schiavetti, Maria Pia Sormani, Antonio Uccelli · 2020 · Multiple Sclerosis Journal
  13. Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury
    Christian Bime, Nancy G. Casanova, Janko Nikolich‐Žugich, Kenneth S. Knox, Sara M. Camp, Joe G. N. Garcia · 2020 · Translational research
  14. COVID-19 Immunobiology: Lessons Learned, New Questions Arise
    Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. Gorgoulis, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas · 2021 · Frontiers in Immunology
  15. The role of HMGB1 in COVID‐19‐induced cytokine storm and its potential therapeutic targets: A review
    Sri Wulandari, Hartono Hartono, Tri Wibawa · 2022 · Immunology
  16. Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles
    Shima Shahbaz, Najmeh Bozorgmehr, Julia Lu, Mohammed S. Osman, Wendy Sligl, D. Lorne Tyrrell, Shokrollah Elahi · 2023 · Microbiology Spectrum
  17. Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic
    Madson Queiroz Almeida, Berenice Bilharinho Mendonca · 2020 · Clinics
  18. Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics
    Ritika Kabra, Shailza Singh · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  19. Testis and blood-testis barrier in Covid-19 infestation: role of angiotensin-converting enzyme 2 in male infertility
    Olugbemi Tope Olaniyan, Ayobami Dare, Gloria Enevwo Okotie, Charles Oluwaseun Adetunji, Babatunde Oluwaseun Ibitoye, Bamidele Joseph Okoli, Olugbenga O. Eweoya · 2020 · Journal of Basic and Clinical Physiology and Pharmacology
  20. Diverse roles of long non‐coding RNAs in viral diseases
    L. H. GINN, Manuela La Montagna, Qinghua Wu, Lei Shi · 2020 · Reviews in Medical Virology
  21. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
    Hadeel T. Al-Jighefee, Hadi Mohamad Yassine, Maryam Ali Al‐Nesf, Ali Ait Hssain, Sara Taleb, Ahmed S. Mohamed, Hassen Maatoug, Mohamed Gaafar Hussein Mohamedali, Gheyath K. Nasrallah · 2021 · Pathogens
  22. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
    Holger A. Lindner, Sonia Y. Velásquez, Manfred Thiel, Thomas Kirschning · 2021 · Frontiers in Immunology
  23. How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era
    Jonathan Caron, Laura A. Ridgley, Mark D. Bodman‐Smith · 2021 · Frontiers in Immunology
  24. Hypoxia and viral infectious diseases
    Richard Huang, Melissa Huestis, Esther Shuyi Gan, Eng Eong Ooi, Michael Ohh · 2021 · JCI Insight
  25. Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation
    Young-Jin Youn, Yu-Bin Lee, Sun-Hwa Kim, Hee Kyung Jin, Jae‐sung Bae, Chang-Won Hong · 2021 · Immune Network
  26. Impact of Sleep Deprivation on Emotional Regulation and the Immune System of Healthcare Workers as a Risk Factor for COVID 19: Practical Recommendations From a Task Force of the Latin American Association of Sleep Psychology
    Katie Moraes de Almondes, Hernán Andrés Marín Agudelo, Ulises Jiménez‐Correa · 2021 · Frontiers in Psychology
  27. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
    Martine Policard, Sidharth S Jain, Samantha Rego, Sivanesan Dakshanamurthy · 2021 · Virus Research
  28. Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
    Luis García de Guadiana‐Romualdo, Mónica Martínez Martínez, María Dolores Rodríguez Mulero, Patricia Esteban-Torrella, Marta Hernández Olivo, María José Alcaraz García, Valerio Campos‐Rodríguez, Natalia Sancho‐Rodríguez, María Galindo Martínez, Antonia Alcaraz et al. · 2021 · International Journal of Infectious Diseases
  29. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
    Jonathan D. Ravid, Orly Leiva, Vipul Chimanlal Chitalia · 2022 · Cells
  30. Delicate regulation of IL-1β-mediated inflammation by cyclophilin A
    Wenxian Yang, Xiaoyuan Bai, Xiaohan Luan, Jie Min, Xiaodong Tian, Heqiao Li, Huizi Li, Wenqiang Sun, Wei Liu, Wenhui Fan et al. · 2022 · Cell Reports
  31. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology
    Jairo Ramos Temerozo, Natalia Fintelman Rodrigues, Monique Cristina dos Santos, Eugênio Damaceno Hottz, Carolina Q. Sacramento, Aline de Paula Dias da Silva, Samuel Coelho Mandacaru, Emilly Caroline dos Santos Moraes, Monique R. O. Trugilho, João Silveira Moledo Gesto et al. · 2022 · Microbiome
  32. Neonatal and Children’s Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy
    Shokrollah Elahi · 2020 · The Journal of Immunology
  33. Clinical characteristics of individuals with Down syndrome deceased with CoVID‐19 in Italy—A case series
    Emanuele Rocco Villani, Angelo Carfì, Antonella Di Paola, Luigi Palmieri, Chiara Donfrancesco, Cinzia Lo Noce, Domenica Taruscio, Paola Meli, Paolo Salerno, Yllka Kodra et al. · 2020 · American Journal of Medical Genetics Part A
  34. Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends
    Sinan Kardeş, Ali Suat Kuzu, Rahul Raiker, Haig H. Pakhchanian, Mine Karagülle · 2020 · Rheumatology International
  35. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
    Sara Chiappalupi, Laura Salvadori, Aleksandra Vukašinović, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi · 2021 · Life Sciences
  36. Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis‐Associated Mechanisms
    Tianliang Ma, Yong Zhou, Ci Wang, Lu Wang, Jingxian Chen, Hui‐Hui Yang, Chen-Yu Zhang, Yong Zhou, Cha‐Xiang Guan · 2021 · Oxidative Medicine and Cellular Longevity
  37. COVID-19 Coagulopathy: From Pathogenesis to Treatment
    Teba Alnima, Mark M. G. Mulder, Bas C. T. van Bussel, Hugo Ten Cate · 2022 · Acta Haematologica
  38. Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
    SubbaRao V. Tulimilli, Siva Dallavalasa, Chaithanya G. Basavaraju, Vinay Kumar Rao, Prashanth Chikkahonnaiah, SubbaRao V. Madhunapantula, Ravindra P. Veeranna · 2022 · Vaccines
  39. Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
    Jeremy P. Gygi, Cole P. Maguire, Ravi K. Patel, Pramod S. Shinde, Anna Konstorum, Casey P. Shannon, Leqi Xu, Annmarie Hoch, Naresh Doni Jayavelu, Impacc Network et al. · 2024 · Journal of Clinical Investigation
  40. New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
    Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, Claudia P. Campillay-Véliz, Camila Salazar‐Ardiles, Andrea M. Avellaneda, Christian A. Muñoz, Angello R Retamal-Díaz, Susan M. Bueno, Pablo A. González et al. · 2024 · Frontiers in Immunology
  41. Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading?
    Ashish Prasad, Manoj Prasad · 2020 · Frontiers in Medicine
  42. BCG vaccination induced protection from COVID-19
    Prasanta Raghab Mohapatra, Baijayantimala Mishra, Bijayini Behera · 2020 · Indian Journal of Tuberculosis
  43. Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae
    Stefano Pallanti, Eleonora Grassi, Nikos Makris, Gregory P. Gasic, Eric Hollander · 2020 · Journal of Psychiatric Research
  44. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
    Roshini Sarah Abraham, Joanna M. Marshall, Hye Sun Kuehn, Cesar Mauricio Rueda, Amber Gibbs, Will Guider, Claire A. Stewart, Sergio D. Rosenzweig, Huanyu Wang, Sophonie Jean et al. · 2020 · Journal of Allergy and Clinical Immunology
  45. Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
    Drishya Kurup, Christoph Wirblich, Holly R. Ramage, Matthias J. Schnell · 2020 · npj Vaccines
  46. Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study
    Xuesong Wen, Dan Jiang, Lei Gao, Jian-zhong Zhou, Jun Xiao, Xiaocheng Cheng, Bin He, Yue Chen, Lei Peng, Xiao‐Wei Tan et al. · 2021 · BMC Infectious Diseases
  47. Markers Associated with COVID-19 Susceptibility, Resistance, and Severity
    Aisha D. Fakhroo, Asmaa A. Al Thani, Hadi Mohamad Yassine · 2020 · Viruses
  48. Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
    Qiong Zhou, Michael Robert MacArthur, Xin‐Liang He, Xiao‐Shan Wei, Payam Zarin, Bola S. Hanna, Zi-Hao Wang, Xuan Xiang, Eleanor N. Fish · 2020 · Viruses
  49. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development
    Hsiang‐Wei Huang, Cheng‐Chih Chang, Chia‐Siu Wang, Kwang‐Huei Lin · 2021 · Cells
  50. SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
    Peyman Kheirandish Zarandi, Mohammad Reza Zinatizadeh, Maryam Zinatizadeh, Mohammad Hadi Yousefi, Nima Rezaei · 2021 · Biomedicine & Pharmacotherapy
  51. Anti-inflammatory activity of soluble chito-oligosaccharides (CHOS) on VitD3-induced human THP-1 monocytes
    Paiboon Jitprasertwong, Munthipha Khamphio, Phornsiri Petsrichuang, Vincent G. H. Eijsink, Wanangkan Poolsri, Chatchai Muanprasat, Kuntalee Rangnoi, Montarop Yamabhai · 2021 · PLoS ONE
  52. Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients
    Varun K. Phadke, Nicholas Scanlon, Stanley C. Jordan, Nadine Rouphael · 2021 · Current Transplantation Reports
  53. A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
    Suresh Kumar, Rosemarie de Souza, Milind Nadkar, Randeep Guleria, Anjan Trikha, Shashank Joshi, Subramanian Loganathan, Sivakumar Vaidyanathan, Ashwani Marwah, Sandeep N. Athalye · 2021 · Expert Opinion on Biological Therapy
  54. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls
    Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, Lis M. Yapanto, Mohsen Nabi‐Afjadi, Mohsen Aksoun, Maryam Nasr Esfahani, Fatemeh Aghakhani, Mahsa Movahed et al. · 2021 · International Immunopharmacology
  55. Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2
    Pravas Kumar Baral, Jiang Yin, Michael N.G. James · 2021 · International Journal of Biological Macromolecules
  56. Primary Adrenal Insufficiency Due to Bilateral Adrenal Infarction in COVID-19
    Iza Franklin Roza Machado, Isabel Q Menezes, Sabrina Rodrigues de Figueiredo, Fernando Morbeck Almeida Coelho, Débora Raquel Benedita Terrabuio, Davi Viana Ramos, Gustavo F C Fagundes, Ana Alice W Maciel, Ana Cláudia Latronico, Maria Candida Barisson Villares Fragoso et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
  57. COVID-19 associated mucormycosis: Staging and management recommendations (Report of a multi-disciplinary expert committee)
    Hardeep Singh Malhotra, Prashant Gupta, Divya Mehrotra, Himanshu R. Dandu, Neera Kohli, Veerendra Verma, Apjit Kaur, Neeraj Kumar, Vikas Vittal Prabhu, Manish Kumar Singh et al. · 2021 · Journal of Oral Biology and Craniofacial Research
  58. Plasma Phospholipids: A Promising Simple Biochemical Parameter to Evaluate COVID-19 Infection Severity
    Mohammed Abdalla Hussein, Noor Eldin Mohamed Ismail, Ahmed Mohamed, Rita Mohammed Ahmed Borik, Ali Ali, Yasser Omar Mosaad · 2021 · Bioinformatics and Biology Insights
  59. Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
    Eman A. Alefishat, Herbert Franz Jelinek, Mira Mousa, Guan K. Tay, Habiba S. AlSafar · 2022 · Journal of Infection and Public Health
  60. Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19
    Xixi Jing, Min Xu, Deye Song, Tingting Yue, Yali Wang, Pan Zhang, Yanjun Zhong, Min Zhang, Tommy Tsan‐Yuk Lam, Nuno Rodrigues Faria et al. · 2022 · Immunity & Ageing
  61. The potential impact of Covid-19 on CNS and psychiatric sequels
    Ali Dehghani, Elham Zokaei, Seyyed Mohammad Kahani, Elaheh Alavinejad, Mohammad Dehghani, Gholam Hossein Meftahi, Mohammad Reza Afarinesh · 2022 · Asian Journal of Psychiatry
  62. Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
    Wurm, Hannah, Attfield, Kate, Iversen, Astrid KN, Gold, Ralf, Fugger, Lars, Haghikia, Aiden · 2020 · Multiple Sclerosis Journal
  63. The impact of SARS-CoV-2 on skeletal muscles.
    Maria Rita De Giorgio, Stefania Di Noia, Cinzia Morciano, Diana Conte · 2020 · PubMed Central
  64. The nasopharyngeal microbiome in COVID-19
    S. Candel, Sylwia D. Tyrkalska, Carmen Álvarez-Santacruz, V. Mulero · 2023 · Emerging Microbes and Infections
  65. Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
    Alessandra Aiello, Saeid Najafi Fard, Delia Goletti · 2023 · Frontiers in Immunology
  66. Thyroid Autoimmunity and SARS-CoV-2 Infection
    Poupak Fallahi, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Eugenia Balestri, Valeria Mazzi, Salvatore Benvenga, Gilda Varricchi, Laura Gragnani et al. · 2023 · Journal of Clinical Medicine
  67. Carboxymethylated Abrus cantoniensis polysaccharide prevents CTX-induced immunosuppression and intestinal damage by regulating intestinal flora and butyric acid content
    Hongjie Hu, Wenjing Sun, Lifang Zhang, Yuan Zhang, Tiantian Kuang, Dongshuai Qu, Shuaitao Lian, Shanshan Hu, Ming Cheng, Yanping Xu et al. · 2024 · International Journal of Biological Macromolecules
  68. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2
    Rolf F. Barth, Louis Maximilian Buja, Anil Vasdev Parwani · 2020 · Diagnostic Pathology
  69. Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
    Claudia Matteucci, Antonella Minutolo, Emanuela Balestrieri, Vita Petrone, Marialaura Fanelli, Vincenzo Malagnino, Marco Ianetta, Alessandro Giovinazzo, Filippo Barreca, Silvia Di Cesare et al. · 2020 · Open Forum Infectious Diseases
  70. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19
    Jintao Zhang, Chunyuan Zhao, Wei Zhao · 2021 · Frontiers in Immunology
  71. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19
    Sreus A. G. Naidu, Taylor C. Wallace, Kelvin J.A. Davies, A. Satyanarayan Naidu · 2021 · Journal of Dietary Supplements
  72. Integrative omics provide biological and clinical insights into acute respiratory distress syndrome
    Mulong Du, Joe G. N. Garcia, Jason D. Christie, Junyi Xin, Guoshuai Cai, Nuala J. Meyer, Zhaozhong Zhu, Qianyu Yuan, Zhengdong Zhang, Li Su et al. · 2021 · Intensive Care Medicine
  73. Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1
    Kiarash Saleki, Mohammad Banazadeh, Niloufar Sadat Miri, Abbas Azadmehr · 2021 · Reviews in the Neurosciences
  74. Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection
    Anuradha Rajamanickam, Nathella Pavan Kumar, Chandrasekaran Padmapriyadarsini, Arul Nancy, Nandhini Selvaraj, Kushiyasri Karunanithi, Saravanan Munisankar, BM Shrinivasa, Rachel Mariam Renji, T.C. Ambu et al. · 2021 · Journal of Infection
  75. Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India
    Nirav K. Nimavat, Shruti Singh, Pratibha Singh, Sunil Kumar Singh, Nishi Sinha · 2021 · Annals of Medicine and Surgery
  76. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
    Antonio Pérez‐Martínez, Marta Mora-Rillo, Cristina Ferreras, Pilar Guerra‐García, Bárbara Pascual-Miguel, Carmen Mestre‐Durán, Alberto Manuel Borobia, Antonio J. Carcas, Javier Queiruga‐Parada, Irene Garcia et al. · 2021 · EClinicalMedicine
  77. Long Covid-19 syndrome as a fourth phase of Sars-CoV2 infection
    Silvia Staffolani, Valentina Iencinella, Matteo Cimatti, Marcello Tavio · 2022 · Infezioni in Medicina
  78. SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control
    Sreus A. G. Naidu, Roger Clemens, A. Satyanarayan Naidu · 2022 · Journal of Dietary Supplements
  79. JAK inhibition as a new treatment strategy for patients with COVID-19
    Jin Huang, Chi Zhou, Deng Jinniu, Jianfeng Zhou · 2022 · Biochemical Pharmacology
  80. The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in Baghdad, Iraq
    Anwar Mohamed Rasheed, Dhurgham F Fatak, Hashim A. Hashim, Mohammed Fauzi Maulood, Khulood K Kabah, Yaqoob A. Almusawi, Ahmed Sahib Abdulamir · 2020 · medRxiv
  81. Clinical learnings from a virtual primary care program monitoring mild to moderate COVID-19 patients at home
    Nicholas Pimlott, Payal Agarwal, Lisa M. McCarthy, Miles J. Luke, Susan Hum, Sumeet Gill, Ruth Heisey · 2020 · Family Practice
  82. Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade
    Antonio Vitiello, Raffaele La Porta, Vilma D’Aiuto, Francesco Ferrara · 2021 · Human Immunology
  83. Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
    Zhengchao Lv, Qin Li, Zaixiong Feng, Xi Zheng, NaYin, Haihao Yang, Qianlan Gu, Sai Ying, Yan Qi, Xiaosi Li et al. · 2021 · International Immunopharmacology
  84. Pediatric cancer research: Surviving COVID‐19
    Jeffery James Auletta, Peter C. Adamson, J. Agin, Pamela R. Kearns, Scott Kennedy, Mark W. Kieran, Donna Ludwinski, Leona Knox, Kristi McKay, Pia Rhiner et al. · 2020 · Pediatric Blood & Cancer
  85. Challenges in heart transplantation during COVID-19: A single-center experience
    Aditi Singhvi, Maya H. Barghash, Anuradha Lala, Sumeet Singh Mitter, Aditya G. Parikh, Estefanía Oliveros, Brett Rollins, Danielle L. Brunjes, Jesus Alvarez Garcia, E. Johnston et al. · 2020 · The Journal of Heart and Lung Transplantation
  86. Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes
    Maria Ida Maiorino, Giuseppe Bellastella, Miriam Longo, Paola Caruso, Katherine Esposito · 2020 · Frontiers in Endocrinology
  87. Novel coronavirus infection COVID-19: extrapulmonary manifestations
    Igor Veniaminovich Maev, A. Shpektor, E. Yu. Vasilyeva, Манчуров Владимир Николаевич, Д. Н. Андреев · 2020 · Terapevticheskii arkhiv
  88. Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19
    Marco Antônio M. Pretti, Rômulo Gonçalves Agostinho Galvani, Gustavo Fioravanti Vieira, Adriana Cesar Bonomo, Martín Bonamino, Mariana Boroni · 2020 · Frontiers in Immunology
  89. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Faria N. Ahmed, Donghyeon Jo, Seung‐Hwan Lee · 2020 · Frontiers in Immunology
  90. Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
    Rachel S. Cooper, Alasdair R. Fraser, Linda M. Smith, Paul Burgoyne, Stuart N. Imlach, LISA M. JARVIS, David M. Turner, Sharon Zahra, Marc L. Turner, John D. Campbell · 2021 · Frontiers in Immunology
  91. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review
    Bilade Cherqaoui, Isabelle Koné‐Paut, Hélène Yager, Fleur Le Bourgeois, Maryam Piram · 2021 · Lara D. Veeken
  92. Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
    Anna Kovalchuk, Bo Wang, Dongping Li, Rocio Rodriguez‐Juarez, Slava Ilnytskyy, Igor Kovalchuk, Olga Kovalchuk · 2021 · Aging
  93. Morphologic Changes in Circulating Blood Cells of COVID-19 Patients
    Gagandeep Kaur, Fnu Sandeep, Oluwaseyi Olayinka, Gunjan Gupta · 2021 · Cureus
  94. Possible role of purinergic signaling in COVID-19
    Maria Luiza Mukai Franciosi, Millena Daher Medeiros Lima, Maria Rosa Chitolina Schetinger, Andréia Machado Cardoso · 2021 · Molecular and Cellular Biochemistry
  95. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation
    Shrinjana Dhar, Pritha Bhattacharjee · 2021 · Journal of Functional Foods
  96. Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective
    Gideon Ampoma Gyebi, Oludare Michael Ogunyemi, Ibrahim M. Ibrahim, Saheed Olanrewaju Afolabi, Joseph Oluwatope Adebayo · 2021 · Computers in Biology and Medicine
  97. Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case–control study
    Nasser M. Al‐Daghri, Osama Emam Amer, Naif H. Alotaibi, Dara A. Aldisi, Mushira A. Enani, Eman Sheshah, Naji J. Aljohani, Naemah M. Alshingetti, Suliman Yousef Alomar, Hanan Alfawaz et al. · 2021 · Journal of Translational Medicine
  98. Molecular mimicry between SARS‐CoV‐2 and the female reproductive system
    Arad Dotan, Darja Kanduc, Sylviane Muller, Alexander Davidovich Makatsariya, Yehuda Shoenfeld · 2021 · American Journal of Reproductive Immunology
  99. Role of the Microbiome in the Pathogenesis of COVID-19
    Rituparna De, Shanta Dutta · 2022 · Frontiers in Cellular and Infection Microbiology
  100. Role of Dendritic Cells in Viral Brain Infections
    Constant, Orianne, Maarifi, Ghizlane, Blanchet, Fabien P., Van de Perre, Philippe, Simonin, Yannick, Salinas, Sara · 2022 · Frontiers in Immunology